Study begins to see if vaginal ring coated with AIDS drug helps protect African women from HIV

WASHINGTON – U.S. researchers are beginning to study several thousand women in Africa to see if inserting a vaginal ring coated with an anti-AIDS drug can protect them from HIV infection.

Giving women a tool to protect themselves when their partners won’t use a condom is crucial for battling the epidemic. Half of the 34.2 million people with HIV worldwide are female.

Previous research found an anti-AIDS vaginal gel could protect women but using it every time they had sex was a hurdle. The vaginal ring, in contrast, would have to be inserted just once a month for continuous protection. Unlike contraceptive rings sold in the U.S., it contains no birth control.

The study, announced Tuesday at the International AIDS Conference, will be conducted in Malawi, Uganda, South Africa, Zambia and Zimbabwe.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.